相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pancancer survival analysis of cancer hallmark genes
Adam Nagy et al.
SCIENTIFIC REPORTS (2021)
EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survival
Sachie Hirai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
Sampath K. Loganathan et al.
SCIENCE (2020)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment
Veronica Gatti et al.
MOLECULAR ONCOLOGY (2019)
Recent advances in the development of Mcl-1 inhibitors for cancer therapy
Alexander W. Hird et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant for lung adenocarcinoma cells
Makoto Tada et al.
LUNG CANCER (2019)
Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
Qiuyuan Wen et al.
DIAGNOSTIC PATHOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck
Rachel J. Carter et al.
CELL DEATH & DISEASE (2019)
Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis
Seiji Arai et al.
CLINICAL CANCER RESEARCH (2018)
Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition
Clare E. Weeden et al.
ONCOGENE (2018)
Exploiting MCL1 Dependency with Combination MEK+MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer
Varuna Nangia et al.
CANCER DISCOVERY (2018)
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Merino et al.
CANCER CELL (2018)
Deciphering the cells of origin of squamous cell carcinomas
Adriana Sanchez-Danes et al.
NATURE REVIEWS CANCER (2018)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial
Takehito Shukuya et al.
LANCET ONCOLOGY (2015)
Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology A Retrospective Study of 103 Cases With Surgical Correlation
Luisella Righi et al.
CANCER (2011)
Neisseria lactamica attenuates TLR-1/2-induced cytokine responses in nasopharyngeal epithelial cells using PPAR-γ
L. B. Tezera et al.
CELLULAR MICROBIOLOGY (2011)
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass et al.
NATURE GENETICS (2009)
分享论文
